Searchable abstracts of presentations at key conferences in endocrinology

ea0081p162 | Pituitary and Neuroendocrinology | ECE2022

Pituitary apoplexy: a retrospective study in a pituitary reference unit

Giron Giselle , Camara-Gomez Rosa , Hernandez Lorena , Lopez Regina , Vera Elena , Francisco Merino Torres Juan

Pituitary apoplexy (PA) is a rare syndrome that requires urgent assistance. It is due to ischemia or hemorrhage of pituitary tissue, almost always inside a pituitary tumor. PA may be the first manifestation of a neuroendocrine tumor or occur during follow up.Objective: To describe the characteristics of patients with PA treated in the Department of Endocrinology and Nutrition in the last 10 years and study the presence of possible risk factors for it.</p...

ea0073ep88 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Rooibos tea (Aspalathus linearis) upregulates hepatic sex hormone-binding globulin production

Laura Briansó Llort , Pheiffer Carmen , Fuertes Rioja Lidia , Ramos Perez Lorena , Hernandez Cristina , Simo Canonge Rafael , Martinez David

Sex hormone-binding globulin (SHBG) is a circulating plasma glycoprotein produced by the liver, which in the blood binds estrogens and androgens with high affinity and regulates its bioavailability. Low plasma SHBG levels are associated with obesity, metabolic syndrome and non-alcoholic fatty liver disease. Importantly, epidemiological studies have demonstrated that low plasma SHBG levels is a risk factor for developing type 2 diabetes and cardiovascular disease. In the last y...

ea0090ep599 | Endocrine-related Cancer | ECE2023

Treatment with 177Lu-dotatate in metastasic advanced neuroendocrine tumors with positive expression of somatostatin receptors, in a third level hospital in Spain from 2015–2022

Giron Giselle , Hernandez Lorena , ISABEL DEL OLMO GARCIA MARIA , Camara-Gomez Rosa , Bello Pilar , Prado Stephan , Segura Angel , Francisco Merino Torres Juan

Introduction: 177Lu-Oxodotreotide(PRRT-Lu) has the approval by EMA and FDA since 2017 for the treatment of patients with gastro-entero-pancreatic neuroendocrine tumors(GEP-NET). However, in daily clinical practice it has also been used in other NET tumors such as paragangliomas, lung NET, medullary thyroid cancer, and others. The aim of this study is to describe the characteristics and follow-up of patients treated with PRRT-Lu in a third level hospital in Spain fro...

ea0081p371 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Body composition in patients undergoing liver transplantation

Argente Pla Maria , Garcia-Malpartida Katherine , Lopez-Gironas Regina , Martin-Sanchis Silvia , Mico-Garcia Andrea , Gasco Eva , Dura-De Miguel Angela , Hernandez Lorena , Vera Elena , Merino Torres Juan Francisco

RationaleLiver cirrhosis frequently leads to changes in body composition consisting of a loss of lean mass, increased body water and variable alterations of fat mass. Changes in body composition may occur after liver transplantation (LT). Our aim was to study the changes that occur in body composition after LT (in the postoperative period after LT as well as 1 month later). Methods: A body composition study was carried out using th...